Article
Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentation.
Multiple sclerosis (Houndmills, Basingstoke, England) - 1 Nov 2021
Dahlke Frank, Arnold Douglas L, Aarden Piet, Ganjgahi Habib, Häring Dieter A, Čuklina Jelena, Nichols Thomas E, Gardiner Stephen, Bermel Robert, Wiendl Heinz
Abstract excerpt
BACKGROUND: The Oxford Big Data Institute, multiple sclerosis (MS) physicians and Novartis aim to address unresolved questions in MS with a novel comprehensive clinical trial data set. OBJECTIVE: The objective of this study is to describe the Novartis-Oxford MS (NO.MS) data set and to explore the relationships between age, disease activity and disease worsening across MS phenotypes. METHODS: We report key...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.